HomeHeMo Bioengineering Ltd

HeMo Bioengineering Ltd

HeMo Bioengineering Receives China’s NMPA Approval for Flagship Afentta Aspiration Catheter

Afentta™ flagship aspiration catheter offers an efficacious, fast and safe direct aspiration treatment option for acute ischemic stroke thrombectomy and has demonstrated lower post stroke treatment disability rates and disease burden from clinical studies.